Serum vitamin B12‐binding proteins in a case of eosinophilic leukemia

Charles A. Coltman, Frank Panettiere, Ralph Carmel

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


A patient with subacute eosinophilic leukemia is presented, with full recognition of the controversy surrounding that entity. Serum vitamin B12 and B12 ‐binding protein studies and simultaneous complete blood counts were done before and during 6 months of high‐dose, intermittent combination chemotherapy. The patient presented with extremely high levels of serum vitamin B12, unsaturated B12‐binding capacity, and transcobalamin I, all of which resembled the highest values seen in chronic myelogenous leukemia. Serial studies, during and after remission induction, showed a precipitous fall of serum vitamin B12 and unsaturated B12‐binding capacity to normal levels. The data show that transcobalamin I levels, which eventually reached low‐normal range, correlate best with the level of circulating and bone marrow eosinophils. Transcobalamin II and serum third binder appeared to be normal throughout the patient's course. The B12‐binding protein abnormalities are not considered diagnostic of eosinophilic leukemia.

Original languageEnglish (US)
Pages (from-to)185-193
Number of pages9
JournalMedical and Pediatric Oncology
Issue number3
StatePublished - 1975
Externally publishedYes


  • eosinophil
  • leukemia
  • vitamin B binding

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Cancer Research


Dive into the research topics of 'Serum vitamin B12‐binding proteins in a case of eosinophilic leukemia'. Together they form a unique fingerprint.

Cite this